Swiss Lonza to buy US capsule maker Capsugel from KKR for $5.5 billion

Swiss pharmaceutical manufacturer Lonza Group AG said it agreed to buy Capsugel, a New Jersey-based maker of capsule drug delivery systems, from private equity firm KKR & Co. for $5.5 billion – More...